Literature DB >> 21853301

Upregulation of B7-H1 expression is associated with macrophage infiltration in hepatocellular carcinomas.

Jie Chen1, Guosheng Li, Hong Meng, Yuchen Fan, Yonghong Song, Shurong Wang, Faliang Zhu, Chun Guo, Lining Zhang, Yongyu Shi.   

Abstract

The overexpression of B7-H1 in hepatocellular carcinoma (HCC) mediates HCC immune escape and obstructs the immunotherapy based on tumor-specific CD8+ T cells. Tumor-associated macrophages (TAM) are a major component of cancer-related inflammation and play a central role in tumor promotion. To classify the mechanism underlying the overexpression of B7-H1 in HCC, we examined B7-H1 expression and TAM infiltration in 63 cases of human HCC samples using immunohistochemistry method and found that B7-H1 overexpression was associated with TAM infiltration in HCC tissues. Furthermore, B7-H1 expression was upregulated at both mRNA level and protein level in HCC cells (BEL-7402 and SMMC-7721) cocultured with macrophages in a transwell system. The upregulation of B7-H1 expression induced by macrophage was inhibited by blocking NF-κB or STAT3 signal pathways. These results suggest that overexpression of B7-H1 in HCC may be induced by inflammatory microenvironment involving macrophages and imply that anti-inflammation therapy might be preventive for immune escape and assistant for immunotherapy of HCC.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21853301     DOI: 10.1007/s00262-011-1094-3

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  39 in total

1.  Prognostic and clinicopathological significance of PD-L1 in patients with renal cell carcinoma: a meta-analysis based on 1863 individuals.

Authors:  Zhun Wang; Shuanghe Peng; Hui Xie; Linpei Guo; Qiliang Cai; Zhiqun Shang; Ning Jiang; Yuanjie Niu
Journal:  Clin Exp Med       Date:  2018-01-23       Impact factor: 3.984

Review 2.  Clinicopathological and prognostic value of programmed death ligand-1 (PD-L1) in renal cell carcinoma: a meta-analysis.

Authors:  Feng Xu; Lingling Xu; Qian Wang; Guangyu An; Guosheng Feng; Fuquan Liu
Journal:  Int J Clin Exp Med       Date:  2015-09-15

Review 3.  Immunotherapeutic approaches to hepatocellular carcinoma treatment.

Authors:  Alexander G Miamen; Haidong Dong; Lewis R Roberts
Journal:  Liver Cancer       Date:  2012-11       Impact factor: 11.740

4.  Expression of costimulatory molecules B7-H1, B7-H4 and Foxp3+ Tregs in gastric cancer and its clinical significance.

Authors:  Yiting Geng; Hui Wang; Changqing Lu; Qing Li; Bin Xu; Jingting Jiang; Changping Wu
Journal:  Int J Clin Oncol       Date:  2014-05-09       Impact factor: 3.402

5.  Evidence for a role of the PD-1:PD-L1 pathway in immune resistance of HPV-associated head and neck squamous cell carcinoma.

Authors:  Sofia Lyford-Pike; Shiwen Peng; Geoffrey D Young; Janis M Taube; William H Westra; Belinda Akpeng; Tullia C Bruno; Jeremy D Richmon; Hao Wang; Justin A Bishop; Lieping Chen; Charles G Drake; Suzanne L Topalian; Drew M Pardoll; Sara I Pai
Journal:  Cancer Res       Date:  2013-01-03       Impact factor: 12.701

6.  Expression of B7-H4 and hepatitis B virus X in hepatitis B virus-related hepatocellular carcinoma.

Authors:  Bo Hong; Yun Qian; Hong Zhang; Yi-Wen Sang; Lin-Fang Cheng; Qi Wang; Song Gao; Min Zheng; Hang-Ping Yao
Journal:  World J Gastroenterol       Date:  2016-05-14       Impact factor: 5.742

7.  B7-H1 expression model for immune evasion in human papillomavirus-related oropharyngeal squamous cell carcinoma.

Authors:  Odey C Ukpo; Wade L Thorstad; James S Lewis
Journal:  Head Neck Pathol       Date:  2012-11-20

8.  Expression of Programmed Death-Ligand 1 in Laryngeal Carcinoma and its Effects on Immune Cell Subgroup Infiltration.

Authors:  Dan Yu; Jinzhang Cheng; Kai Xue; Xue Zhao; Lianji Wen; Chengbi Xu
Journal:  Pathol Oncol Res       Date:  2018-10-25       Impact factor: 3.201

9.  Macrophage-derived CCL5 facilitates immune escape of colorectal cancer cells via the p65/STAT3-CSN5-PD-L1 pathway.

Authors:  Chao Liu; Zhaoying Yao; Jianing Wang; Wen Zhang; Yan Yang; Yan Zhang; Xinliang Qu; Yubing Zhu; Jianjun Zou; Sishi Peng; Yan Zhao; Shuli Zhao; Bangshun He; Qiongyu Mi; Xiuting Liu; Xu Zhang; Qianming Du
Journal:  Cell Death Differ       Date:  2019-12-04       Impact factor: 15.828

Review 10.  Natural Killer Cells and Regulatory T Cells Cross Talk in Hepatocellular Carcinoma: Exploring Therapeutic Options for the Next Decade.

Authors:  Amber G Bozward; Frazer Warricker; Ye H Oo; Salim I Khakoo
Journal:  Front Immunol       Date:  2021-04-30       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.